Loading...
NPI 1699115857 · Phoenix, AZ · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Accupath Diagnostic Laboratories Inc is a clinical medical laboratory provider located in Phoenix, Arizona. This profile covers 42 Medicare and 35 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Accupath Diagnostic Laboratories Inc |
| Address | 5005 S 40th St |
| City | Phoenix |
| State | AZ |
| ZIP | 85040 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | July 2, 2013 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $4.1M |
| Medicare | $3.3M |
Provider payer mix and scale: ACCUPATH DIAGNOSTIC LABORATORIES INC reports lifetime Medicare revenue of $3.3M and lifetime Medicaid revenue of $4.1M, making Medicaid the larger single public-payer source of recorded revenue. The dual-payer footprint is multi-million-dollar but tilted toward Medicaid, so analyses of state-level reimbursement and utilization will be material to understanding overall volume and cash flow.
Medicare revenue concentration by code: the top three Medicare codes (81479, 88185, 81450) account for 38.8% of this provider's total Medicare revenue, signaling meaningful concentration in a small set of high-revenue services. Notably, 81479 contributes $667.4K revenue (20.9% of Medicare revenue) while 88185 and 81450 add $292.5K (9.2%) and $281.2K (8.8%) respectively, so shifts in reimbursement or utilization for these codes would have outsized impact on Medicare receipts.
Medicaid revenue concentration and service-line dominance: the top three Medicaid codes (88185, 88237, 88264) account for 57.2% of this provider's total Medicaid revenue, with 88185 alone representing $1.9M revenue (46.0% of Medicaid revenue). This heavy concentration around 88185 indicates a dominant flow cytometry service line in the Medicaid population and means changes to flow cytometry demand or state coverage could materially affect Medicaid revenue.
Business and clinical service-line profile: the code mix is concentrated in molecular pathology, flow cytometry, cytogenetics/FISH, and immunohistochemistry—examples include high Medicare revenue for 81479 ($667.4K), 81450 ($281.2K), and elevated volumes for cytogenetics codes such as 88275 ($222.4K) and 88264 ($200.6K). Together these codes point to an operational focus on hematology/oncology-related testing and complex molecular diagnostics rather than general clinical lab testing, implying specialized laboratory capabilities and likely a referral-oriented workflow.
National competitive standing on Medicare for specialized assays: the provider ranks at or near the top nationally for several specialized codes, for example 88275 is rank #3 of 72 (97th percentile; extreme outlier) and 88271 is rank #3 of 74 (97th percentile; extreme outlier), while 88341 is rank #52 of 10274 (100th percentile; extreme outlier). Those rank/percentile labels indicate this lab reports unusually high national volumes for multiple cytogenetic and IHC services, positioning it as a notable national-volume performer for selected specialized tests.
State-level dominance on Medicaid: the provider is the top in-state performer for multiple high-revenue Medicaid codes, including 88185 (rank #1 of 15 in-state, 100th percentile; notably above typical state volume), 88237 (rank #1 of 6, 100th percentile; notably above typical state volume), and 88264 (rank #1 of 5, 100th percentile; notably above typical state volume). These state-level ranks show the provider is a major Arizona source for flow cytometry and cytogenetic testing within the Medicaid population, which strengthens its negotiating relevance with in-state providers and payers who manage those services.
Statistical outlier pattern and operational implication: multiple codes are explicitly labeled as "extreme outlier" or "notably above typical" in their rank descriptors (examples include 88275, 88271, 88341, 81219), indicating concentrated, unusually high volumes for specialized assays. This clustering of outlier labels suggests a defined specialization or regional referral role rather than broad-based low-complexity testing, and it highlights both opportunity (market leadership in niche assays) and concentration exposure if demand or policy for those assays changes.
Tenure and footprint context: the NPI was enumerated on 2013-07-02 (~13 years ago), and over that tenure the provider has accumulated a multi-million-dollar public-payer footprint across Medicare ($3.3M) and Medicaid ($4.1M). That combination of a decade-plus operating history and concentrated, high-volume specialty lines supports the interpretation of a mid-sized, specialized diagnostic laboratory with established presence in Arizona and measurable national standing on select complex tests.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
42 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 81479 | Use 81479 to report a molecular pathology procedure that does not have a specific code. | 820 | $810 | $667.4K |
| 88185 | The lab analyst performs the technical component of a flow cytometry procedure using cell surface, cytoplasmic, or nuclear markers to characterize cells and aid clinicians in diagnosing patients with… | 18,280 | $20 | $292.5K |
| 81450 | The lab analyst performs a genomic sequence analysis panel to evaluate the patient specimen, such as blood or bone marrow, for DNA and possibly RNA alterations in five to 50 genes known to impact… | 380 | $740 | $281.2K |
| 88275 | The analyst performs a molecular cytogenetic test using interphase in situ hybridization and analyzes 100 to 300 cells. Interphase refers to a period of time when a cell is not dividing and… | 4,450 | $50 | $222.4K |
| 88237 | The lab analyst performs a procedure to grow a culture of cells from bone marrow or blood in a neoplastic disorder. | 1,550 | $140 | $218.6K |
| 88264 | The analyst performs a chromosome analysis and analyzes 20 to 25 cells. The analysis includes counting the number of chromosomes in each cell and preparing a karyotype for each cell examined. | 1,410 | $140 | $200.6K |
| 81279 | The lab analyst performs the technical lab test on a specimen such as blood to analyze specific gene sequences of the JAK2 (Janus kinase 2) gene, such as exons 12 and 13, which may be associated with… | 920 | $180 | $168K |
| 88271 | The analyst performs a molecular cytogenetic test using a DNA probe method, such as FISH, fluorescence in situ hybridization, to test cells for genetic abnormalities. | 6,580 | $20 | $138.3K |
| 81338 | The lab analyst performs the technical lab test on a specimen such as blood to analyze common variants of specific gene sequences of the MPL (MPL proto–oncogene, thrombopoietin receptor) gene, such… | 910 | $150 | $134.4K |
| 88341 | The lab analyst applies an additional single antibody stain on a slide or slides prepared from the same patient specimen as the initial antibody stain, such as tumor tissue. Then a qualified… | 3,280 | $40 | $114.7K |
Showing 1–10 of 42
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 42 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
42 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 81479 | 2 | 10 | 560 | $3,210 | $17.3M |
| 81450 | 1 | 10 | 220 | $740 | $160.8K |
| 81338 | 1 | 10 | 910 | $150 | $134.7K |
| 88237 | 1 | 10 | 810 | $140 | $114.3K |
| 81279 | 1 | 10 | 470 | $180 | $84.9K |
| 88275 | 1 | 10 | 280 | $50 | $81.8K |
| 88264 | 1 | 10 | 70 | $140 | $72.5K |
| 88305 | 141 | 270 | 700 | $40 | $71.1K |
| 88185 | 1 | 20 | 920 | $20 | $61.2K |
| 81219 | 1 | 10 | 490 | $120 | $57.8K |
Showing 1–10 of 42
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
35 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 88185 | The lab analyst performs the technical component of a flow cytometry procedure using cell surface, cytoplasmic, or nuclear markers to characterize cells and aid clinicians in diagnosing patients with… | 8,420 | $220 | $1.9M |
| 88237 | The lab analyst performs a procedure to grow a culture of cells from bone marrow or blood in a neoplastic disorder. | 5,120 | $50 | $250.8K |
| 88264 | The analyst performs a chromosome analysis and analyzes 20 to 25 cells. The analysis includes counting the number of chromosomes in each cell and preparing a karyotype for each cell examined. | 4,080 | $50 | $203.8K |
| 88184 | The lab analyst performs the technical component of a flow cytometry procedure using a cell surface, cytoplasmic, or nuclear marker to characterize cells and aid clinicians in diagnosing patients… | 8,220 | $20 | $197.2K |
| 88341 | The lab analyst applies an additional single antibody stain on a slide or slides prepared from the same patient specimen as the initial antibody stain, such as tumor tissue. Then a qualified… | 2,610 | $70 | $193K |
| 88189 | The clinician, typically a pathologist, interprets flow cytometry results of 16 or more markers. | 5,540 | $30 | $188.5K |
| 88275 | The analyst performs a molecular cytogenetic test using interphase in situ hybridization and analyzes 100 to 300 cells. Interphase refers to a period of time when a cell is not dividing and… | 3,380 | $50 | $175.5K |
| 88360 | The lab analyst applies a single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist, evaluates the… | 4,630 | $40 | $162.1K |
| 88271 | The analyst performs a molecular cytogenetic test using a DNA probe method, such as FISH, fluorescence in situ hybridization, to test cells for genetic abnormalities. | 3,410 | $40 | $143.2K |
| 88377 | The lab analyst applies a single multiplex in situ hybridization probe stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a… | 1,280 | $100 | $129.1K |
Showing 1–10 of 35
How this provider's Medicaid billing volume and revenue compare to other Arizona providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Arizona median
35 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 81455 | The lab analyst performs a genomic sequence analysis panel to evaluate the patient specimen, such as tumor tissue or bone marrow, for DNA and possibly RNA alterations in 51 or more genes known to… | 4 | 10 | 60 | $500 | $572.2K |
| 81235 | The lab analyst performs the technical lab test to detect the presence of common changes in the gene for epidermal growth factor receptor, also known as EGFR. | 2 | 10 | 8,490 | $70 | $562.5K |
| 88185 | The lab analyst performs the technical component of a flow cytometry procedure using cell surface, cytoplasmic, or nuclear markers to characterize cells and aid clinicians in diagnosing patients with… | 1 | 20 | 430 | $240 | $453.1K |
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 122 | 140 | 1,460 | $60 | $422.5K |
| 81275 | The lab analyst performs the technical lab test to detect the presence of common changes in the gene Kirsten rat sarcoma viral oncogene homolog, also known as KRAS, which occur in exon 2. | 2 | 10 | 8,540 | $40 | $369.6K |
| 88360 | The lab analyst applies a single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist, evaluates the… | 2 | 10 | 160 | $70 | $303.9K |
| 81276 | The lab analyst performs the technical lab test to detect the presence of additional variants, other than in exon 2, for the gene Ki–ras2 Kirsten rat sarcoma viral oncogene, also known as KRAS. | 2 | 10 | 7,730 | $40 | $298.9K |
| 81403 | The lab analyst performs the technical lab test to complete one of the specific genetic analyses listed in this Tier 2, Level 4 molecular pathology code. | 2 | 10 | 360 | $60 | $267.6K |
| 81210 | The lab analyst performs the technical lab test to detect the presence of common changes in the gene for B–Raf proto–oncogene, serine/threonine kinase, also known as BRAF. | 2 | 10 | 6,540 | $30 | $213.8K |
| 81279 | The lab analyst performs the technical lab test on a specimen such as blood to analyze specific gene sequences of the JAK2 (Janus kinase 2) gene, such as exons 12 and 13, which may be associated with… | 2 | 10 | 5,830 | $30 | $202.3K |
Showing 1–10 of 35
Other providers in the same ZIP code as Accupath Diagnostic Laboratories Inc, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Caris Mpi, Inc. | AZ | Clinical Medical Laboratory | $97.4M | $51.7M |
| New Life Wellness Center LLC | AZ | Public Health or Welfare Agency | $0 | $66M |
| Family And Youth Intervention Services | AZ | Community/Behavioral Health Agency | $0 | $16.2M |
| Nebco Associates, Inc. | AZ | Transportation Broker | $0 | $11.4M |
| Central Clinical Labs Incorporated | AZ | Clinical Medical Laboratory | $3.5M | $6.1M |
| Sahar Samaha | AZ | Anatomic Pathology & Clinical Pathology Physician | $906.4K | $0 |
| Joshua Leonard | AZ | Optometrist | $347.1K | $0 |
| Abida Kadi | AZ | Dermatopathology (Pathology) Physician | $267K | $0 |
| Hema Khurana | AZ | Anatomic Pathology & Clinical Pathology Physician | $235.5K | $0 |
| Spencer Wotring | AZ | Certified Registered Nurse Anesthetist | $35.3K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.